
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $23.6M | $69.5M | $28.3M | $86.5M | $105M | |
Revenue Growth (YoY) | -64.43% | 194.6% | -59.28% | 205.64% | 21.31% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $8.2M | $10M | $11.5M | $10.7M | $9.4M | |
Other Inc / (Exp) | -$26.6M | $26K | -$36.5M | -$28M | -$2.3M | |
Operating Expenses | $8.2M | $10M | $10M | $10.2M | $9.2M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $15.5M | $59.6M | $18.3M | $76.4M | $95.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $15.5M | $59.6M | $18.3M | $76.4M | $95.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $15.5M | $59.6M | $18.3M | $76.4M | $95.8M | |
Basic EPS (Cont. Ops) | $0.37 | $1.41 | $0.35 | $1.40 | $1.76 | |
Diluted EPS (Cont. Ops) | $0.37 | $1.41 | $0.35 | $1.40 | $1.76 | |
Weighted Average Basic Share | $42.3M | $42.3M | $51.7M | $54.6M | $54.6M | |
Weighted Average Diluted Share | $42.3M | $42.3M | $51.7M | $54.6M | $54.6M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $42.6M | $89.4M | $64.4M | $148.9M | $167.2M | |
Revenue (Reported) | $23.6M | $69.5M | $28.3M | $86.5M | $105M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $42.6M | $89.4M | $64.4M | $148.9M | $167.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $24M | $5.4M | $9.7M | $30.1M | $22.1M | |
Revenue Growth (YoY) | -- | -77.33% | 78.5% | 209.53% | -26.5% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.5M | $4M | $3M | $2.3M | $2.2M | |
Other Inc / (Exp) | -$366K | $30K | $687K | $135K | -$422K | |
Operating Expenses | $2.5M | $4M | $2.9M | $2.2M | $2.2M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $21.5M | $1.5M | $6.8M | $27.9M | $19.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $21.5M | $1.5M | $6.8M | $27.9M | $19.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $21.5M | $1.5M | $6.8M | $27.9M | $19.9M | |
Basic EPS (Cont. Ops) | $0.51 | $0.04 | $0.13 | $0.51 | $0.37 | |
Diluted EPS (Cont. Ops) | $0.51 | $0.04 | $0.13 | $0.51 | $0.37 | |
Weighted Average Basic Share | $42.3M | $42.3M | $54.6M | $54.6M | $54.6M | |
Weighted Average Diluted Share | $42.3M | $42.3M | $54.6M | $54.6M | $54.6M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $28.7M | $9.8M | $22.1M | $46.1M | $35.8M | |
Revenue (Reported) | $24M | $5.4M | $9.7M | $30.1M | $22.1M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $28.7M | $9.8M | $22.1M | $46.1M | $35.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $120.8M | $51M | $32.6M | $106.9M | $97M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $8.4M | $11.4M | $10.5M | $9.9M | $9.3M | |
Other Inc / (Exp) | -$27M | $422K | -$35.8M | -$28.5M | -$2.8M | |
Operating Expenses | $8.4M | $11.4M | $8.9M | $9.5M | $9.2M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $112.4M | $39.5M | $23.7M | $97.4M | $87.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $112.4M | $39.5M | $23.7M | $97.4M | $87.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $112.4M | $39.5M | $23.7M | $97.4M | $87.8M | |
Basic EPS (Cont. Ops) | $2.67 | $0.95 | $0.45 | $1.78 | $1.62 | |
Diluted EPS (Cont. Ops) | $2.67 | $0.95 | $0.45 | $1.78 | $1.62 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $139.8M | $70.5M | $76.7M | $172.8M | $156.9M | |
Revenue (Reported) | $120.8M | $51M | $32.6M | $106.9M | $97M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $139.8M | $70.5M | $76.7M | $172.8M | $156.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $24M | $5.4M | $9.7M | $30.1M | $22.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.5M | $4M | $3M | $2.3M | $2.2M | |
Other Inc / (Exp) | -$366K | $30K | $687K | $135K | -$422K | |
Operating Expenses | $2.5M | $4M | $2.9M | $2.2M | $2.2M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $21.5M | $1.5M | $6.8M | $27.9M | $19.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $21.5M | $1.5M | $6.8M | $27.9M | $19.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $21.5M | $1.5M | $6.8M | $27.9M | $19.9M | |
Basic EPS (Cont. Ops) | $0.51 | $0.04 | $0.13 | $0.51 | $0.37 | |
Diluted EPS (Cont. Ops) | $0.51 | $0.04 | $0.13 | $0.51 | $0.37 | |
Weighted Average Basic Share | $42.3M | $42.3M | $54.6M | $54.6M | $54.6M | |
Weighted Average Diluted Share | $42.3M | $42.3M | $54.6M | $54.6M | $54.6M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $28.7M | $9.8M | $22.1M | $46.1M | $35.8M | |
Revenue (Reported) | $24M | $5.4M | $9.7M | $30.1M | $22.1M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $28.7M | $9.8M | $22.1M | $46.1M | $35.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $388.8M | $322.9M | $428.3M | $344.2M | $414.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $571K | $567K | $664K | $608K | $571K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $404M | $339.9M | $450.4M | $368.5M | $443.2M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $1.5B | $1.7B | $2.1B | $2.2B | $2B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $1.9B | $2B | $2.5B | $2.5B | $2.4B | |
Accounts Payable | $400.8M | $341.9M | $433M | $339.8M | $405.3M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $410.1M | $353.8M | $447.9M | $355.7M | $422.3M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1B | $1.2B | $1.5B | $1.5B | $1.5B | |
Common Stock | $423K | $423K | $546K | $546K | $546K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $852M | $842.3M | $999.7M | $986.6M | $992.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $852M | $842.3M | $999.7M | $986.6M | $992.9M | |
Total Liabilities and Equity | $1.9B | $2B | $2.5B | $2.5B | $2.4B | |
Cash and Short Terms | $388.8M | $322.9M | $428.3M | $344.2M | $414.3M | |
Total Debt | $671.5M | $812M | $1.1B | $1.2B | $1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $357.8M | $588.9M | $444.4M | $308.1M | $467M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $752K | $927K | $855K | $930K | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $375.9M | $605.9M | $466.9M | $333.6M | $497.4M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $1.6B | $1.6B | $2.1B | $2.1B | $2B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2B | $2.2B | $2.6B | $2.5B | $2.5B | |
Accounts Payable | $374.1M | $587.9M | $439.2M | $299.8M | $453.1M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $385.8M | $595.7M | $453.1M | $315.9M | $470.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1B | $1.4B | $1.6B | $1.5B | $1.5B | |
Common Stock | $423K | $423K | $546K | $546K | $546K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $856.2M | $826.4M | $984.2M | $992.1M | $990.5M | |
Total Liabilities and Equity | $2B | $2.2B | $2.6B | $2.5B | $2.5B | |
Cash and Short Terms | $357.8M | $588.9M | $444.4M | $308.1M | $467M | |
Total Debt | $705.8M | $808.9M | $1.1B | $1.2B | $1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $15.5M | $59.6M | $18.3M | $76.4M | $95.8M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $3.4M | -$9.9M | -$9.4M | -$13.4M | -$11.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$61.4M | -$135.1M | $91.1M | -$76.9M | $309.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$69.3M | -$69.3M | -$94.5M | -$97M | -$89.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $337M | $862.1M | $978.9M | $1.1B | $501.4M | |
Long-Term Debt Repaid | -$253.9M | -$723.5M | -$867M | -$970M | -$651.2M | |
Repurchase of Common Stock | -- | -- | -$3M | -$10K | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $13.8M | $69.3M | $14.3M | -$7.3M | -$239.2M | |
Beginning Cash (CF) | $436.4M | $388.8M | $322.9M | $428.3M | $344.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$47.6M | -$65.8M | $105.4M | -$84.2M | $70.1M | |
Ending Cash (CF) | $388.8M | $322.9M | $428.3M | $344.2M | $414.3M | |
Levered Free Cash Flow | -$61.4M | -$135.1M | $91.1M | -$76.9M | $309.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $21.5M | $1.5M | $6.8M | $27.9M | $19.9M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$2.7M | -$745K | -$3.6M | -$3.9M | -$3.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$47.7M | $304.2M | $9.5M | $7.3M | $68.1M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$17.3M | -$34.7M | -$22.4M | -$22.4M | -$22.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $146M | $192.4M | $166M | $105M | $294.3M | |
Long-Term Debt Repaid | -$112M | -$196M | -$137M | -$126M | -$287.3M | |
Repurchase of Common Stock | -- | -- | -$10K | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $16.7M | -$38.3M | $6.6M | -$43.4M | -$15.4M | |
Beginning Cash (CF) | $388.8M | $322.9M | $428.3M | $344.2M | $414.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$31M | $266M | $16.1M | -$36M | $52.7M | |
Ending Cash (CF) | $357.8M | $588.9M | $444.4M | $308.1M | $467M | |
Levered Free Cash Flow | -$47.7M | $304.2M | $9.5M | $7.3M | $68.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $112.4M | $39.5M | $23.7M | $97.4M | $87.8M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$3.4M | -$6.2M | -$12.2M | -$13.7M | -$11M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$248.3M | $216.8M | -$203.7M | -$79M | $370.1M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$69.3M | -$86.6M | -$82.3M | -$96.9M | -$89.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $452M | $908.5M | $952.5M | $998.7M | $690.7M | |
Long-Term Debt Repaid | -$262M | -$807.5M | -$808M | -$959M | -$812.5M | |
Repurchase of Common Stock | -- | -- | -$3M | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $120.5M | $14.3M | $59.2M | -$57.3M | -$211.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$127.8M | $231.1M | -$144.5M | -$136.3M | $158.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$248.3M | $216.8M | -$203.7M | -$79M | $370.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $21.5M | $1.5M | $6.8M | $27.9M | $19.9M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$2.7M | -$745K | -$3.6M | -$3.9M | -$3.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$47.7M | $304.2M | $9.5M | $7.3M | $68.1M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$17.3M | -$34.7M | -$22.4M | -$22.4M | -$22.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $146M | $192.4M | $166M | $105M | $294.3M | |
Long-Term Debt Repaid | -$112M | -$196M | -$137M | -$126M | -$287.3M | |
Repurchase of Common Stock | -- | -- | -$10K | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $16.7M | -$38.3M | $6.6M | -$43.4M | -$15.4M | |
Beginning Cash (CF) | $388.8M | $322.9M | $428.3M | $344.2M | $414.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$31M | $266M | $16.1M | -$36M | $52.7M | |
Ending Cash (CF) | $357.8M | $588.9M | $444.4M | $308.1M | $467M | |
Levered Free Cash Flow | -$47.7M | $304.2M | $9.5M | $7.3M | $68.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.